These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19157178)

  • 1. Retrograde embolization after balloon angioplasty in a patient with late stent subthrombosis in a paclitaxel-eluting stent.
    De Wolf A; Basoglu A; Vranckx P; Benit E
    Acta Cardiol; 2008 Dec; 63(6):797-9. PubMed ID: 19157178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very late thrombosis of paclitaxel-eluting stent.
    Aytekin V; Erdim R; Gormez S; Demiroglu C
    Cardiovasc Revasc Med; 2008; 9(4):275-7. PubMed ID: 18928954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late thrombosis in paclitaxel-eluting stent after discontinuation of clopidogrel medication - a case report with 2-year follow-up].
    Wozakowska-Kapłon B; Młodnicki M; Gutkowski W
    Kardiol Pol; 2009 Mar; 67(3):299-303; discussion 304. PubMed ID: 19378238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents.
    de Abreu LM; Meireles GC; Sumita MK; Forte AA; Aliaga Jdel C; Hayashi J
    Arq Bras Cardiol; 2007 May; 88(5):e111-4. PubMed ID: 17589614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction.
    Rigattieri S; Patrizi R; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Palamara A; Loschiavo P
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):771-4. PubMed ID: 17001240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous late stent thrombosis in two coronary arteries following drug-eluting stent implantation.
    Prasad SB; Malaiapan Y; Ahmar W; Meredith IT
    Cardiovasc Revasc Med; 2009; 10(3):188-90. PubMed ID: 19595402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very late thrombosis of a paclitaxel-eluting stent after 72 months in a patient on dual anti-platelet therapy.
    Subban V; Kalidoss L; Sankardas MA
    Cardiovasc J Afr; 2012 Apr; 23(3):e9-11. PubMed ID: 22555757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.
    Nakazawa G; Finn AV; Vorpahl M; Ladich ER; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2011 Jan; 57(4):390-8. PubMed ID: 21251578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
    Sardella G; Bucciarelli-Ducci C; Mancone M; Colantonio R; Sangiorgi GM; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):625-8. PubMed ID: 17667035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
    Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
    JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late stent thrombosis after paclitaxel-eluting stent placement in a patient with essential thrombocytosis.
    Keleş T; Bayram NA; Durmaz T; Bozkurt E
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):558-60. PubMed ID: 21248457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
    Räber L; Magro M; Stefanini GG; Kalesan B; van Domburg RT; Onuma Y; Wenaweser P; Daemen J; Meier B; Jüni P; Serruys PW; Windecker S
    Circulation; 2012 Mar; 125(9):1110-21. PubMed ID: 22302840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
    Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
    JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
    Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous two-vessel very-late stent thrombosis of everolimus-eluting stents.
    Puri A; Saireddy R; McClean D
    J Invasive Cardiol; 2013 Mar; 25(3):E48-50. PubMed ID: 23468452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.